Fournier gangrene future or investigational therapies: Difference between revisions
Jump to navigation
Jump to search
Category |
m Bot: Removing from Primary care |
||
Line 7: | Line 7: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Emergency mdicine]] | |||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Up-To-Date]] | [[Category:Up-To-Date]] | ||
[[Category:Infectious disease]] | [[Category:Infectious disease]] |
Latest revision as of 21:47, 29 July 2020
Fournier gangrene Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Fournier gangrene future or investigational therapies On the Web |
American Roentgen Ray Society Images of Fournier gangrene future or investigational therapies |
FDA on Fournier gangrene future or investigational therapies |
Fournier gangrene future or investigational therapies in the news |
Blogs onFournier gangrene future or investigational therapies |
Risk calculators and risk factors for Fournier gangrene future or investigational therapies |
Steven C. Campbell, M.D., Ph.D.; Associate Editor(s)-in-Chief: Yamuna Kondapally, M.B.B.S[1]; Jesus Rosario Hernandez, M.D. [2]